Akitoshi Yuge

No ORCID on file · 21 papers in corpus · active 2006-2016

Study types

  • article 18
  • review 2
  • book-chapter 1

Condition tags

  • endometriosis 17
  • endometrioma 3
article 2016
article 2015

ABSTR ACT: Mayer-Rokitanski-Kuster-Hauser (MRKH) syndrome is a rare disease. A 27-year-old woman was admitted for primary amenorrhea and cyclic pelvic pain. Magnetic resonance imaging (MRI) revealed bilateral Müllerian remnants with functio…

article 2014
Japanese clinical medicine ·doi:10.4137/jcm.s12611

Mayer-Rokitanski-Kuster-Hauser (MRKH) syndrome is a rare disease. A 27-year-old woman was admitted for primary amenorrhea and cyclic pelvic pain. Magnetic resonance imaging (MRI) revealed bilateral Müllerian remnants with functioning endome…

book-chapter 2014
·doi:10.1007/978-4-431-54421-0_16
article 2013
article 2012
article 2012
review 2011
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719110392059

Endometriosis, a disease affecting 3% to 10% of women of reproductive age, is characterized by the ectopic growth of endometrial tissue under the influence of estrogen. It is also becoming recognized as a condition in which ectopic endometr…

article 2011
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2011-1503

CONTEXT: During the development of endometriotic lesions, excess fibrosis may lead to scarring and to the alterations of tissue function that are the characteristic features of this disease. Enhanced extracellular matrix contractility of en…

article 2010
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2010.10.026
article 2010
·doi:10.2174/157436210791112154

Endometriosis, a disease affecting 3-10% of women of reproductive age, is characterized by the ectopic growth of endometrial tissue. Histologically, this disease is characterized by endometrial gland and stroma with surrounding dense fibrou…

article 2009
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2009-0207

CONTEXT: Decidualization of the endometrium involves the morphological and biochemical reprogramming of the estrogen-primed proliferative endometrial stromal compartment under the continuing influence of progesterone. OBJECTIVES: The aim of…

article 2009
Fertility and sterility ·doi:10.1016/j.fertnstert.2009.02.057
review 2009
Histology and histopathology ·doi:10.14670/hh-24.1181

Endometriosis, a disease affecting 3-10% of women of reproductive age, is characterized by the ectopic growth of endometrial tissue. Increasingly, endometriosis is also becoming recognized as a condition in which ectopic endometrial cells e…

article 2009
Fertility and sterility ·doi:10.1016/j.fertnstert.2009.06.055
article 2007
Human Reproduction ·doi:10.1093/humrep/del485

BACKGROUND: Excessive fibrosis is frequently associated with endometriosis. To evaluate the involvement of the extracellular matrix contractility of endometriotic stromal cells (ECSCs) in the pathogenesis of endometriosis-associated fibrosi…

article 2007
·doi:10.2174/1573404810703020113

Endometriosis, a disease affecting 3-10% of women of reproductive age, is characterized by the ectopic growth of endometrial tissue. Increasingly, endometriosis is also becoming recognized as a condition in which ectopic endometrial cells e…

article 2006
American journal of physiology. Endocrinology and metabolism ·doi:10.1152/ajpendo.00135.2006

Most of the current medical treatments for endometriosis aim to downregulate estrogen activity. However, a high recurrence rate after medical treatment has been the most significant problem. BAY 11-7085, a soluble inhibitor of NK-kappaB act…

article 2006
·doi:10.1016/j.jsgi.2006.03.007
article 2006
·doi:10.1080/08916930600929487

The aim of the present study was to evaluate the effects of interleukin (IL)-1beta on the production of vascular endothelial growth factor (VEGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) in the human fallopian tube. Human oviductal e…

article 2006
Human Reproduction ·doi:10.1093/humrep/del270

BACKGROUND: Most of the current medical treatments for endometriosis aim to down-regulate the estrogen activity. However, a high recurrence rate after medical treatments has been the most significant problem. Beta-hydroxyisovalerylshikonin …